PoliCheck Network
← Back to bills
H.R. 6845119th CongressReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

S.T.O.P. Illicit Vapes Act

Introduced: Dec 18, 2025
Latest action: Dec 18, 2025

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

1
Primary Sponsors
3
Cosponsors
2
Recorded Actions
0
Linked Votes

Plain-English AI Summary

What this bill means

Generated from the official bill text to make the legislation easier to understand.

Not Generated

A plain-English AI summary has not been generated for this bill yet.

Official Summary

Official legislative summary associated with this bill.

No official summary is currently available.

Primary Sponsors

Members listed as primary sponsors of this legislation.

Cosponsors

Members who joined this legislation as cosponsors.

Recorded Actions

Official legislative actions recorded for this measure.

H11100Dec 18, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Official source ↗
Intro-HDec 18, 2025

Introduced in House

Official source ↗

Linked Votes

Roll-call votes associated with this legislation.

No roll-call votes are currently linked to this bill.

Lobbying Activity

Federal lobbying disclosures that explicitly identify H.R. 6845. These records show reported lobbying involving the legislation; they do not establish that every member of Congress, sponsor, or voter was personally contacted.

AMERICAN LUNG ASSOCIATION

Registrant: AMERICAN LUNG ASSOCIATION

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Budget/Appropriations: Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act; HR 9495, Department of Defense Appropriations Act, 2027 Clean Air and Water (quality): Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to "Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to "New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled "Reconsideration of the National Ambient Air Quality Standards for Particulate Matter"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act;; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act ; SHOWER Act; Affordable HOMES Act; HR 4690, Reliable Federal Infrastructure Act; HR 2165, Choice in Automobile Retail Sales Act; HR 3194, LOCOMOTIVES Act; HR 6200, ESSENTIAL Act; HR 6250, Cold Weather Diesel Reliability Act; HR 7000, Freedom to Fuel Act; HR 8782, PLOW Storms Act; HR 2140, Diesel Emissions Reduction Act of 2025; HR 8870, Build America 250 Act; HR 9022, Fiscal Year 2027 Energy and Water Appropriations Bill; S 4732, Wildfire Smoke Emergency Declaration Act; HR 9243, Wildfire Smoke Emergency Declaration Act; HR 9453, End EPA Abuse Act; S 4931, End EPA Abuse Act; HR 9171, Department of Interior, Environment and Related Agencies Appropriations Act, 207; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; HR 9170, Transportation, Housing and Urban Development and Related Agencies Appropriations Act, 2027; HR 6387, Fire Improvement and Reforming Exceptional Events Act; HR 6409, Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 9317, Buses Utilizing Safety and Environmental Standards Act; HR 9618, Diesel Engine Flexibility Act; HR 1346, To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes; S 4404, No Passes for Polluters Act Health Issues: Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act;;; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 Medical/Disease Research/Clinical Labs: Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; ;; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act; HR 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 Medicare/Medicaid: Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act Defense: Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program;; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026; HR 9495, Department of Defense Appropriations Act, 2027 Tobacco: Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; HR 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; S 4257, Resources to Prevent Youth Vaping Act Taxation/Internal Revenue Code: Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 Veterans: Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes

Government entities reported: Centers For Disease Control & Prevention (CDC) Environmental Protection Agency (EPA) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Natl Institutes of Health (NIH) SENATE Energy, Dept of Interior, Dept of (DOI) Internal Revenue Service (IRS) Natl Highway Traffic Safety Administration (NHTSA) Office of Management & Budget (OMB) Transportation, Dept of (DOT) White House Office Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)

Reported filing-period amount: $120,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

ALTRIA CLIENT SERVICES LLC

Registrant: ALTRIA CLIENT SERVICES LLC

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Budget/Appropriations: HR 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2027; Section 766, related to provisions regarding the regulation of tobacco products and provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 9310: Department of Homeland Security Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 8260/S 2587: Departments of Labor, Health and Human Services and Education and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 8845/S 2354: Commerce Justice Science and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 8495: Financial Services and General Government Appropriations Act, 2027; related to provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 8595: National Security, Department of State, and Related Programs Appropriations Act, 2027; related to provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 9170: Transportation Housing and Urban Development and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 6938: FY2026 Consolidated Commerce Justice Science, Energy & Water, Interior Appropriations Act; provisions related to contraband vapor products and the Organized Crime Drug Enforcement Task Force S 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products Tobacco: HR 1798/ S 819: End Tobacco Loopholes Act; all provisions of the bill HR 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; provisions relating to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction and pathways to authorization for tobacco and nicotine products Discussions concerning proposals to ban characterizing flavors in tobacco products Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products Discussions regarding federal excise taxes and the taxation of tobacco products HR 6845: S.T.O.P. Illicit Vapes Act; all provisions of the bill S 3213: Destruction of Hazardous Imports Act; all provisions of the bill S 4303: ENDS Chinese Vapes Act of 2026; all provisions of the bill Discussions related to FDA Guidance on Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Executive Office of the President (EOP) Health & Human Services, Dept of (HHS)

Reported filing-period amount: $3,200,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

ALTRIA CLIENT SERVICES LLC

Registrant: ALTRIA CLIENT SERVICES LLC

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Budget/Appropriations: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2027; provisions related to tobacco and nicotine products Department of Homeland Security Appropriations Act 2027; potential provisions related to tobacco and nicotine products Departments of Labor, Health and Human Services and Education and Related Agencies Appropriations Act 2027; provisions related to tobacco and nicotine products Commerce Justice Science and Related Agencies Appropriations Act 2027; provisions related to tobacco and nicotine products HR 7148: FY2026 Consolidated Defense, Labor-HHS, Nat. Sec.-State, Transportation Housing and Urban Development, Financial Services and General Government Appropriations Act; provisions related to tobacco and nicotine products HR 6938: FY2026 Consolidated Commerce Justice Science, Energy & Water, Interior Appropriations Act; provisions related to contraband vapor products and the Organized Crime Drug Enforcement Task Force Tobacco: HR 1798/ S 819: End Tobacco Loopholes Act; all provisions of the bill HR 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; provisions relating to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction Discussions concerning proposals to ban characterizing flavors in tobacco products Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products Discussions regarding federal excise taxes and the taxation of tobacco products HR 6845: S.T.O.P. Illicit Vapes Act; all provisions of the bill

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $2,950,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN LUNG ASSOCIATION

Registrant: AMERICAN LUNG ASSOCIATION

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Budget/Appropriations: Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; Consolidated Appropriations Act, 2026; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Breaking the Gridlock Act Clean Air and Water (quality): Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to "Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to "New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled "Reconsideration of the National Ambient Air Quality Standards for Particulate Matter"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act; Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026; Protection of Lawful Commerce in Stone Slab Products Act; Home Appliance Protection and Affordability Act; Homeowner Energy Freedom Act; Energy Bills Relief Act; Promoting Reduction of Emissions through Landscaping Act; Discussion Draft of Legislation to Modernize the Toxic Substances Control Act; SHOWER Act; Affordable HOMES Act Health Issues: Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act; Consolidated Appropriations Act, 2026; Breaking the Gridlock Act Medical/Disease Research/Clinical Labs: Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act Medicare/Medicaid: Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025 Defense: Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026 Tobacco: Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act; Resources to Prevent Youth Vaping Act Taxation/Internal Revenue Code: Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 Veterans: Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes

Government entities reported: Centers For Disease Control & Prevention (CDC) Environmental Protection Agency (EPA) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Natl Institutes of Health (NIH) SENATE Energy, Dept of Interior, Dept of (DOI) Internal Revenue Service (IRS) Natl Highway Traffic Safety Administration (NHTSA) Office of Management & Budget (OMB) Transportation, Dept of (DOT) White House Office Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)

Reported filing-period amount: $160,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN LUNG ASSOCIATION

Registrant: AMERICAN LUNG ASSOCIATION

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Budget/Appropriations: Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; HR 5450 Continuing Appropriations and Extensions and Other Matters Act, 2026; S 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; HR 5371 Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 Clean Air and Water (quality): Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to California Clean Air Act waivers; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues related to agency restructuring; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning;; S1072 Stop California from Advancing Regulatory Burden Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; HR 313 Natural Gas Tax Repeal Act; S 143 Natural Gas Tax Repeal Act; HR 471 Fix Our Forests; HJ Res 15/SJ Res 4 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to "Energy Conservation Program: Energy Conservation Standards for Commercial Water Heating Equipment"; HR 903/S 341 Smoke and Heat Ready Communities Act; S 541 Eliminating Lavish Incentives to Electric Vehicles Act; HR 1449 Energy Resilient Communities Act;; S 711 Transportation Freedom Act; HR 1651 To nullify the final rule issued by the Environmental Protection Agency relating to "New Source Performance Standards for Greenhouse Gas Emissions From New, Modified, and Reconstructed Fossil Fuel-Fired Electric Generating Units; Emission Guidelines for Greenhouse Gas Emissions From Existing Fossil Fuel-Fired Electric Generating Units; and Repeal of the Affordable Clean Energy Rule"; HR 1415/S 623 No Industrial Restrictions In Secret (No IRIS) Act; HR 2140 DERA Act 2025; S 1072 A bill to amend the Clean Air Act to eliminate a waiver under that Act, to eliminate an authorization for States to use new motor vehicle emission and new motor vehicle engine emissions standards identical to standards adopted in California, and for other purposes; HR 2165 Choice in Automobile Retail Sales (CARS) Act; HR 346 Preserving Choice in Vehicle Purchases Act; S 990 Freedom to Haul Act; HR 2288 To nullify the final rule of the Environmental Protection Agency titled "Reconsideration of the National Ambient Air Quality Standards for Particulate Matter"; ; HJ Res 30/SJ Res 14 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020"; S 1166 Excess Urban Heat Mitigation Act; HR 4214 To require the Administrator of the Environmental Protection Agency to publish, concurrently with any final rule establishing or revising a national ambient air quality standard, regulations and guidance for implementing the standard, including information relating to submission and consideration of a preconstruction permit application under the new or revised standard, and for other purposes; HR 3889/S 2015 National Prescribed Fire Act; H.Res. 585 Recognizing the threat of extreme weather to childrens health and wellbeing, and expressing the sense of Congress that solutions must be rapidly and equitably developed and deployed to address the unique vulnerabilities and needs of children; HR 4443/S 2298 Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act; S 2340/HR 4515 Climate Change Health Protection and Promotion Act of 2025; HR 4744/S 2445 Community Mental Wellness and Resilience Act; HR 161 New Source Review Permitting Improvement Act; HR HR 6387 Fire Improvement and Reforming Exceptional Events Act; HR 6409 Foreign Emissions and Nonattainment Clarification for Economic Stability Act; HR 6398 Reducing and Eliminating Duplicative Environmental Regulations Act; HR 6373 Air Permitting Improvements to Protect National Security Act; H.R. 4214 Clean Air and Building Infrastructure Improvement Act; HR 5371 Continuing Appropriations and Extensions Act, 2026; HR 5450 Continuing Appropriations and Extensions and Other Matters Act, 2026; S 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; S 2431 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4754 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026; HR 4553 Energy and Water Development and Related Agencies Appropriations Act, 2026; HR 4776 SPEED Act; S 3529 Public Health Air Quality Act; S 3007, Diesel Truck Liberation Act; S 237 Honoring Our Fallen Heroes Act Health Issues: Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to agency restructuring; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3701 Family Vaccine Protection Act; H.R. 3521 Clinical Trial Modernization Act; HR 5371 Continuing Appropriations and Extensions Act, 2026; HR 5450Continuing Appropriations and Extensions and Other Matters Act, 2026; S 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; HR 4417 Mobile Cancer Screening Act HR 3701 Family Vaccine Protection Act; HR 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 6703 Lower Health Care Premiums for All Americans Act; S 2466 Senior Savings Protection Act; HR Senior Savings Protection Act; HR 6052 Elijah E. Cummings Family Asthma Act; HR 6319 Benay Taub Lung Cancer Research Act; HR 45448 Protecting Free Vaccines Act Medical/Disease Research/Clinical Labs: Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to agency restructuring; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; Issues related to Medicaid; H.R. 1509/S. 752, the Accelerating Kids Access to Care Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; H.R. 3521 Clinical Trial Modernization Act; HR 5371 Continuing Appropriations and Extensions Act, 2026; HR 5450 Continuing Appropriations and Extensions and Other Matters Act, 2026; S 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; HR 4417 Mobile Cancer Screening Act; HR 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; S 2587 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; HR 5278/S 2756 Affordable Inhalers and Nebulizers Act of 2025; HR 45448 Protecting Free Vaccines Act Medicare/Medicaid: Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to agency restructuring; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S 1406 the Supplemental Oxygen Access Reform Act; HR 2902 the Supplemental Oxygen Access Reform Act; H.R. 783 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S. 248 Sustainable Cardiopulmonary Rehabilitation Services in the Home Act; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S 717 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025; S 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; HR 6178 Increasing Access to Lung Cancer Screening Act; HR 6321 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025 Defense: Issues related to tobacco use, lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; Issues related to the Congressional Directed Medical Research Program; HR 5371 Continuing Appropriations and Extensions Act, 2026; HR 5450 Continuing Appropriations and Extensions and Other Matters Act, 2026; S 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; HR 4016 Department of Defense Appropriations Act, 2026; S 2572 Department of Defense Appropriations Act, 2026 Tobacco: Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to agency restructuring; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S 77 Early Participation in Regulations Act; S 81 Guidance Clarity Act; HR 77 Midnight Rules Relief Act; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 5371 Continuing Appropriations and Extensions Act, 2026; HR 5450 Continuing Appropriations and Extensions and Other Matters Act, 2026; S 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026; S 2256 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; HR 6844 The Tobacco Tracking, Reporting, and Accountability for Compliance in Enforcement Act; HR 6845 Strengthening Task Force Operations to Prevent Illicit Vaping Act; S 3569 Strengthening Task Force Operations to Prevent Illicit Vaping Act Taxation/Internal Revenue Code: Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY26 appropriations; S 317 Charitable Act; HR 801 Charitable Act; H.Con.Res.14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S.Con.Res 7 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; HR 5371 Continuing Appropriations and Extensions Act, 2026; HR 5450 Continuing Appropriations and Extensions and Other Matters Act, 2026; S 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026 Veterans: Issues related to lung disease treatment, prevention and research; Issues related to burn pits; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to FY25 appropriations; Issues relating to FY26 appropriations; S. 2171 A bill to amend title 38, united States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; HR 5371 Continuing Appropriations and Extensions Act, 2026; HR 5450 Continuing Appropriations and Extensions and Other Matters Act, 2026; S 2882 Continuing Appropriations and Extensions and Other Matters Act, 2026

Government entities reported: Centers For Disease Control & Prevention (CDC) Environmental Protection Agency (EPA) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Natl Institutes of Health (NIH) SENATE Energy, Dept of Interior, Dept of (DOI) Internal Revenue Service (IRS) Natl Highway Traffic Safety Administration (NHTSA) Office of Management & Budget (OMB) Transportation, Dept of (DOT) White House Office Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA)

Reported filing-period amount: $70,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS

Registrant: MASON CONSULTING, LLC

2nd Quarter (Apr 1 - June 30)
Jul 22, 2026

Reported lobbying issue

Immigration: Legislation and policies related to: Detentions and deportation of children and families with children Authorization of the Deferred Action for Childhood Arrivals program Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 1061/S. 455, Protecting Sensitive Locations Act H.R. 6987/S. 3602 - Public Charge Clarification Act of 2025 Budget/Appropriations: Legislation and policies relating to: Potential changes in fiscal year 2026 and fiscal year 2027 funding for nurse education, workforce, and research programs as a result of workforce reductions and reorganization of agencies and programs within the Department of Health and Human Services Appropriations of Title VIII funding for nurse education and nurse workforce development programs and for the National Institute of Nursing Research (NINR) in fiscal years 2026 and 2027 Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) Recognition of nursing as a professional degree in the Department of Education Final Rule, Reimagining and Improving Student Education, Docket ID ED-2025-OPE-0944 H.R. 7147, Further Additional Continuing Appropriations Act, 2026 H.R. 8107, Government Audit and Accountability of Federally Funded State-Administered Programs Act H.R. 8312, Fraud Prevention and Accountability Act H.R. 8464, Stopping Fraudulent Payments Act H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 H.R. 8872, Preventing Waste, Fraud, and Abuse in TANF Act H.R. 9022, Energy and Water Development and Related Agencies Appropriations Act, 2027 H.R. 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S. Con. Res. 33, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2026 and setting forth the appropriate budgetary levels for fiscal years 2027 through 2035 Education: Legislation and policies related to: Accreditation and curriculum of advance practice nursing education programs Policies and requirements related to federal scholarship and loan repayment programs for advanced practice registered nurses Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) Recognition of nursing as a professional degree in the Department of Education Final Rule, Reimagining and Improving Student Education, Docket ID ED-2025-OPE-0944 H.R. 3711/S. 1948, Protecting Our Students by Terminating Graduate Rates that Add to Debt (POST GRAD) Act H.R. 6574, Loan Equity for Advanced Professionals (LEAP) Act H.R. 6677, Professional Degree Access Restoration Act H.R. 6718, Professional Student Degree Act H.R. 6739, Clarity in Professional Degree Act H.R. 6862, Protecting Health Care Workforce Pipelines Act H.R. 8691/S. 4568, Nursing is a Professional Degree Act H.J. Res. 189, Providing for congressional disapprovalof the rule submitted by the Department of Education relating to Reimagining and Improving Student Education-Federal Student Loan Program Final Regulations S. 3435/H.R. 6607, Future Advancement of Academic Nursing (FAAN) Act S. 3707/H.R. 7279, Nurse Faculty Shortage Reduction Act S.J. Res. 196, A joint resolution providing for congressional disapprovalof the rule submitted by the Department of Education relating to Reimagining and Improving Student Education-Federal Student Loan Program Final Regulations Environment/Superfund: Legislation and policies related to: Environmental protections affecting the health and safety of children, families, and health care providers Inflation Reduction Act (P.L. 117-169) provisions related to climate change, clean energy, and environmental health Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 6409/S. 3836, Foreign Emissions and Nonattainment Clarification for Economic Stability (FENCES) Act Health Issues: Legislation and policies relating to: Potential changes in authorizations for nurse education, workforce, and research programs as a result of workforce reductions and reorganization of agencies and programs within the Department of Health and Human Services Policies related to the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, child vaccine recommendations and schedule, the Vaccines For Children Program, and the Vaccine Injury Compensation Fund Cancellation of federal nursing workforce grants Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Use of provider-neutral and inclusive language in federal documents, forms, and surveys Reauthorization of the Child Nutrition Act Implementation of 42 USC 300gg-5(a) regarding provider non-discrimination by health plans Policies affecting nurse practitioner education and workforce Definition, evaluation and enforcement of essential health benefits and provider network adequacy Mental health services and violence prevention Tobacco and vaping prevention and cessation Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 1197/S. 1562, PREEMIE Reauthorization Act H.R. 1435/S. 3714, Family-to-Family Reauthorization Act of 2025 H.R. 1735/S. 779, Early Action and Responsiveness Lifts Youth Minds (EARLY Minds) Act H.R. 2472, Improving Newborns' Food and Nutrition Testing Safety (INFANTS) Act of 2025 H.R. 2493, Improving Care in Rural America Reauthorization Act of 2025 H.R. 3333, Magnifying Opportunities to Recruit and Educate (MORE) Nurses Act H.R. 3492, Protect Childrens Innocence Act H.R. 3624/S. 1924, Improving Mental Health Access for Students Act H.R. 3701, Family Vaccine Protection Act H.R. 3884/S. 2011, Telemental Health Care Access Act H.R. 4262/S. 4110, Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act H.R. 4340/S. 921, Tyler's Law H.R. 4564, Dillons Law H.R. 4709, Newborn Screening Saves Lives Reauthorization Act of 2025 H.R. 4725, Transparency, Readability, Understandability, Truth, and Helpfulness (TRUTH) in Labeling Act H.R. 5145, Bipartisan Premium Tax Credit Extension Act H.R. 5434/S. 2826, 988 LGBTQ+ Youth Access Act of 2025 H.R. 5469/S. 2858, Stillbirth Health Improvement and Education (SHINE) for Autumn Act H.R. 5582, Patients Deserve Price Tags Act H.R. 6088/S. 3281, Restoring Food Security for Families & Farmers Act of 2025 H.R. 6121/S. 2303, Promoting Physical Activity for Americans Act H.R. 6252, Food Assurance and Security Act H.R. 6396, Kid Providing Resources for Optimal Outcomes against Fatalities (Kid PROOF) Act of 2025 H.R. 6561, PREVENT HPV Cancers Act of 2025 H.R. 6703, Lower Health Care Premiums for All Americans Act H.R. 6844, Tobacco TRACE Act H.R. 6845/S. 3569, S.T.O.P. Illegal Vaping Act H.R. 6945/S. 4242, Supporting Pregnant and Parenting Women and Families Act H.R. 7092/S. 4061, Raising Awareness for Youth Suicide (RAYS) Prevention Act H.R. 7567, Farm, Food, and National Security Act of 2026 H.R. 7757, Kids Internet and Digital Safety (KIDS) Act H.R. 7867, Infant Formula Safety Modernization Act of 2026 H.R. 7875, Providing Opportunities for Individuals in Need of Treatment and Support (POINTS) Act H.R. 7973, Momnibus Act H.R. 8081/S. 4202, Mental Health Access and Provider Support Act H.R. 8089/S. 4186, Perinatal Workforce Act H.R. 8163, Provider Reimbursement Stability Act H.R. 8201, Expanding Community Access to Health Services Act H.R. 8209, School-Based Health Centers Reauthorization Act of 2026 H.R. 8385, Food Labeling Modernization Act of 2026 H.R. 8425, Strengthening the Vaccines for Children Program Act of 2026 H.R. 8429, Baby Food Safety Act of 2026 H.R. 8521/S. 4387, Protect Moms from Domestic Violence Act H.R. 8657, Campus Lifeline Act H.R. 9257/S. 4754, Primary and Behavioral Health Care Access Act H.R. 9393, Lower Costs, More Transparency Act of 2026 S. 222/H.R. 649, Whole Milk for Healthy Kids Act of 2025 S. 266/H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act S. 272, Protect Infant Formula from Contamination Act S. 278, Kids Off Social Media Act S. 705, Innovations in Pediatric Drugs Act S. 836/H.R. 6291, Children and Teens Online Privacy Protection Act (COPPA 2.0) S. 891, Bipartisan Health Care Act S. 1157/H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1885, Stop the Scroll Act S. 1482, National Nursing Workforce Center Act of 2025 S. 1599/H.R. 6394, Midwives for Maximizing Optimal Maternity Services (MOMS) Act of 2025 S. 1748/H.R. 6484, Kids Online Safety Act S. 1874/H.R. 3593, Title VIII Nursing Workforce Reauthorization Act of 2025 S. 2169, Rural Hospital Cybersecurity Enhancement Act S. 2857/H.R. 5448, Protecting Free Vaccines Act S. 2954, Health Care Workforce Expansion Act of 2025 S. 3199, 988 Lifeline Location Improvement Act of 2025 S. 3315, Health Care Cybersecurity and Resiliency Act of 2025 S. 3386, Health Care Freedom for Patients Act of 2025 S. 3402, Ensuring Excellence in Mental Health Act S. 3799, Healthy Start Reauthorization Act of 2026 S. 3853, End the Vaccine Carveout Act S. 4088, Welcome Back to the Health Care Workforce Act S. 4141, Rural Hospital Revitalization Act S. 4189, Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act Labor Issues/Antitrust/Workplace: Legislation and policies related to: Workplace safety and violence prevention for nurse, advanced practice registered nurses, and other health care professionals Implementation of 42 USC 300gg-5(a) regarding provider non-discrimination by health plans H.R. 2332/S. 1101, States Handling Access to Reciprocity for Employment (SHARE) Act of 2025 H.R. 2531/S. 1232, Workplace Violence Prevention for Health Care and Social Services Workers Act H.R. 3170/S. 3296, Improving Access to Workers Compensation for Injured Federal Workers Act H.R. 4122/S. 2167, Health Care for Energy Workers Act of 2025 Medicare/Medicaid: Legislation and policies related to: Physician/nurse practitioner reimbursement Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Creation of a Medicare graduate nursing education program Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Medicare and Medicaid policies related to telehealth services Medicaid eligibility expansion and state options Medicaid waiver application procedures Protection and improvement of Medicaid Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) benefit Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21), including the Rural Health Transformation Program Inclusion of nurse practitioners in the bonus program for clinicians practicing in primary care Health Professional Shortage Areas (HPSAs) H.R. 498, Do No Harm in Medicaid Act H.R. 1317/S. 575, Improving Care and Access to Nurses (I CAN) Act H.R. 1616/S. 1805, Promoting Access to Diabetic Shoes Act H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 2531/S. 1232, Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 2586, Reentry Act of 2025 H.R. 3108/S. 1535, Rural Patient Monitoring Access Act H.R. 3684, Save Americas Rural Hospitals Act H.R. 4619, Medicare Mental Health Inpatient Equity Act of 2025 H.R. 4773/S. 3350, ACO Assignment Improvement Act of 2025 H.R. 4849/S. 2556, Protecting Health Care and Lowering Costs Act H.R. 5081/S. 2709, Telehealth Modernization Act H.R. 5199, Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217, Rural Behavioral Health Improvement Act of 2025 H.R. 6199/S. 3934, Medical Nutrition Therapy Act of 2025 H.R. 7106, Enhancing Skilled Nursing Facilities Act H.R. 7787, Mental Health Workforce Act H.R. 7973, Momnibus Act S. 683/H.R. 7324, More Behavioral Health Providers Act S. 717/H.R. 6894, Increasing Access to Quality Cardiac Rehabilitation Care Act S. 1261/H.R. 4206, CONNECT for Health Act of 2025 S. 1816/H.R. 3514, Improving Seniors Timely Access to Care Act S. 2954, Health Care Workforce Expansion Act of 2025 Taxation/Internal Revenue Code: Legislation and policies related to: Taxation of income and benefits and tax incentives affecting nursing education and practice Taxation of non-profit organizations Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 593, Strengthening Pathways to Health Professions Act H.R. 1582/S. 786, Personal Health Investment Today (PHIT) Act H.R. 3145/S. 1548, Nurse Corps Tax Parity Act of 2025 S. 46/H.R. 247, Health Care Affordability Act of 2025 S. 131/H.R. 392, Providing Real-World Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act Veterans: Legislation and policies related to: Revision and implementation of Department of Veterans Affairs regulation RIN 2900-AP44, Advanced Practice Registered Nurses H.R. 2234, Ensuring Veterans Timely Access to Anesthesia Care Act H.R. 8800, National Defense Authorization Act for Fiscal Year 2027 S. 3329/H.R. 6203, U.S. Cadet Nurse Corps Service Recognition Act

Government entities reported: Health & Human Services, Dept of (HHS) Homeland Security, Dept of (DHS) HOUSE OF REPRESENTATIVES SENATE Health Resources & Services Administration (HRSA) Natl Institutes of Health (NIH) Office of Management & Budget (OMB) Education, Dept of Environmental Protection Agency (EPA) Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Labor, Dept of (DOL) Occupational Safety & Health Administration (OSHA) Veterans Affairs, Dept of (VA)

Reported filing-period amount: $24,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

TOBACCO-FREE KIDS ACTION FUND

Registrant: TOBACCO-FREE KIDS ACTION FUND

2nd Quarter (Apr 1 - June 30)
Jul 21, 2026

Reported lobbying issue

Tobacco: Legislation: H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 8845 and Senate bill, FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 9260 and Senate bill, FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 8595 and Senate bill, FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act H.R. 8646 and Senate bill, FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 and Senate farm bill H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes FDA enforcement against unauthorized tobacco products FDA oversight of nicotine pouches FDA regulation of tobacco products Agencies Visited: Food and Drug Administration US House of Representatives US Senate Health Issues: GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 27 Appropriations bills Modernizing Opioid Treatment Access Act S. 1165/H. R. 2586, Reentry Act H.R. 5629 Issues: Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Financing (grants) for behavioral health care services and programs FY 2027 National Drug Control Policy Medicaid funding and federal guidance related to harm reduction Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Substance Abuse and Mental Health Services Administration

Government entities reported: Food & Drug Administration (FDA) HOUSE OF REPRESENTATIVES SENATE Centers For Disease Control & Prevention (CDC) Substance Abuse & Mental Health Services Administration (SAMHSA)

Reported filing-period amount: $300,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

TOBACCO-FREE KIDS ACTION FUND

Registrant: TOBACCO-FREE KIDS ACTION FUND

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Tobacco: Legislation: H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 8845 and Senate bill, FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 9260 and Senate bill, FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 8595 and Senate bill, FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act H.R. 8646 and Senate bill, FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 and Senate farm bill H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes FDA enforcement against unauthorized tobacco products FDA oversight of nicotine pouches FDA regulation of tobacco products Agencies Visited: Food and Drug Administration US House of Representatives US Senate Health Issues: GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 27 Appropriations bills Modernizing Opioid Treatment Access Act S. 1165/H. R. 2586, Reentry Act H.R. 5629 Issues: Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Financing (grants) for behavioral health care services and programs FY 2027 National Drug Control Policy Medicaid funding and federal guidance related to harm reduction Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Substance Abuse and Mental Health Services Administration

Government entities reported: Food & Drug Administration (FDA) HOUSE OF REPRESENTATIVES SENATE Centers For Disease Control & Prevention (CDC) Substance Abuse & Mental Health Services Administration (SAMHSA)

Reported filing-period amount: $284,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

TOBACCO-FREE KIDS ACTION FUND

Registrant: TOBACCO-FREE KIDS ACTION FUND

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Tobacco: Legislation: H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 8845 and Senate bill, FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 9260 and Senate bill, FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 8595 and Senate bill, FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act H.R. 8646 and Senate bill, FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 and Senate farm bill H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes FDA enforcement against unauthorized tobacco products FDA oversight of nicotine pouches FDA regulation of tobacco products Agencies Visited: Food and Drug Administration US House of Representatives US Senate Health Issues: GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 27 Appropriations bills Modernizing Opioid Treatment Access Act S. 1165/H. R. 2586, Reentry Act H.R. 5629 Issues: Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Financing (grants) for behavioral health care services and programs FY 2027 National Drug Control Policy Medicaid funding and federal guidance related to harm reduction Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate Substance Abuse and Mental Health Services Administration

Government entities reported: Food & Drug Administration (FDA) HOUSE OF REPRESENTATIVES SENATE Centers For Disease Control & Prevention (CDC) Substance Abuse & Mental Health Services Administration (SAMHSA)

Reported filing-period amount: $290,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

CAMPAIGN FOR TOBACCO-FREE KIDS

Registrant: CAMPAIGN FOR TOBACCO-FREE KIDS

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Tobacco: Lobbying Report: April 1st - June 30th, 2026 (Campaign) Federal (under tobacco issue code) Legislation: H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 8845 and Senate bill, FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 9260 and Senate bill, FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 8595 and Senate bill, FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act H.R. 8646 and Senate bill, FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 and Senate farm bill H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes FDA enforcement against unauthorized tobacco products FDA oversight of nicotine pouches FDA regulation of tobacco products[LG1.1] Agencies Visited: Food and Drug Administration US House of Representatives US Senate

Government entities reported: Food & Drug Administration (FDA) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS

Registrant: MASON CONSULTING, LLC

1st Quarter (Jan 1 - Mar 31)
Apr 24, 2026

Reported lobbying issue

Budget/Appropriations: Legislation and policies relating to: Potential changes in fiscal year 2026 and fiscal year 2027 funding for nurse education, workforce, and research programs as a result of workforce reductions and reorganization of agencies and programs within the Department of Health and Human Services Appropriations of Title VIII funding for nurse education and nurse workforce development programs and for the National Institute of Nursing Research (NINR) in fiscal years 2026 and 2027 Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) Recognition of nursing as a professional degree in Department of Education Reimagining and Improving Student Education Committee (RISE Committee) Negotiated Rulemaking H.R. 5371, Continuing Appropriations and Extensions Act, 2026 H.R. 6938, Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 H.R. 7147, Further Additional Continuing Appropriations Act, 2026 H.R. 7148, Consolidated Appropriations Act, 2026 S. 2587/H.R. 5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2882, Continuing Appropriations and Extensions and Other Matters Act, 2026 Education: Legislation and policies related to: Accreditation and curriculum of advance practice nursing education programs Policies and requirements related to federal scholarship and loan repayment programs for advanced practice registered nurses Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) Recognition of nursing as a professional degree in Department of Education Reimagining and Improving Student Education Committee (RISE Committee) Negotiated Rulemaking H.R. 3711/S. 1948, Protecting Our Students by Terminating Graduate Rates that Add to Debt (POST GRAD) Act H.R. 6574, Loan Equity for Advanced Professionals (LEAP) Act H.R. 6677, Professional Degree Access Restoration Act H.R. 6718, Professional Student Degree Act H.R. 6739, Clarity in Professional Degree Act H.R. 6862, Protecting Health Care Workforce Pipelines Act S. 3435/H.R. 6607, Future Advancement of Academic Nursing (FAAN) Act S. 3707/H.R. 7279, Nurse Faculty Shortage Reduction Act Environment/Superfund: Legislation and policies related to: Environmental protections affecting the health and safety of children, families, and health care providers Inflation Reduction Act (P.L. 117-169) provisions related to climate change, clean energy, and environmental health Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 4758, Homeowner Energy Freedom Act H.R. 4246, Home Appliance Protection and Affordability Act Health Issues: Legislation and policies relating to: Potential changes in authorizations for nurse education, workforce, and research programs as a result of workforce reductions and reorganization of agencies and programs within the Department of Health and Human Services Policies related to the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, child vaccine recommendations and schedule, the Vaccines For Children Program, and the Vaccine Injury Compensation Fund Cancellation of federal nursing workforce grants Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Use of provider-neutral and inclusive language in federal documents, forms, and surveys Reintroduction of the Primary and Behavioral Health Care Access Act Reauthorization of the Child Nutrition Act Implementation of 42 USC 300gg-5(a) regarding provider non-discrimination by health plans Policies affecting nurse practitioner education and workforce Definition, evaluation and enforcement of essential health benefits and provider network adequacy Mental health services and violence prevention Tobacco and vaping prevention and cessation Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 1197/S. 1562, PREEMIE Reauthorization Act H.R. 1435/S. 3714, Family-to-Family Reauthorization Act of 2025 H.R. 1627, Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 1735/S. 779, Early Action and Responsiveness Lifts Youth Minds (EARLY Minds) Act H.R. 1834, Breaking the Gridlock Act H.R. 1909/S. 2621, Preventing Maternal Deaths Act H.R. 2223, Building Capacity for Care Act H.R. 3333, Magnifying Opportunities to Recruit and Educate (MORE) Nurses Act H.R. 3492, Protect Childrens Innocence Act H.R. 3701, Family Vaccine Protection Act H.R. 3884/S. 2011, Telemental Health Care Access Act H.R. 4262/S. 4110, Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act H.R. 4340/S. 921, Tyler's Law H.R. 4564, Dillons Law H.R. 4709, Newborn Screening Saves Lives Reauthorization Act of 2025 H.R. 5145, Bipartisan Premium Tax Credit Extension Act H.R. 5434/S. 2826, 988 LGBTQ+ Youth Access Act of 2025 H.R. 5469/S. 2858, Stillbirth Health Improvement and Education (SHINE) for Autumn Act H.R. 5629, To provide that the HHS final rule titled Medications for the Treatment of Opioid Use Disorder (except the portion relating to accreditation of opioid treatment programs) shall have no force or effect H.R. 6088/S. 3281, Restoring Food Security for Families & Farmers Act of 2025 H.R. 6252, Food Assurance and Security Act H.R. 6396, Kid Providing Resources for Optimal Outcomes against Fatalities (Kid PROOF) Act of 2025 H.R. 6561, PREVENT HPV Cancers Act of 2025 H.R. 6703, Lower Health Care Premiums for All Americans Act H.R. 6844, Tobacco TRACE Act H.R. 6845/S. 3569, S.T.O.P. Illegal Vaping Act H.R. 6945/S. 4242, Supporting Pregnant and Parenting Women and Families Act H.R. 7092, Raising Awareness for Youth Suicide (RAYS) Prevention Act H.R. 7567, Farm, Food, and National Security Act of 2026 H.R. 7757, Kids Internet and Digital Safety (KIDS) Act H.R. 7973, Momnibus Act H.R. 8089/S. 4186, Perinatal Workforce Act S. 222/H.R. 649, Whole Milk for Healthy Kids Act of 2025 S. 266/H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act S. 272, Protect Infant Formula from Contamination Act S. 278, Kids Off Social Media Act S. 705, Innovations in Pediatric Drugs Act S. 836/H.R. 6291, Children and Teens Online Privacy Protection Act (COPPA 2.0) S. 891, Bipartisan Health Care Act S. 1157/H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1885, Stop the Scroll Act S. 1261, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025 S. 1482, National Nursing Workforce Center Act of 2025 S. 1599/H.R. 6394, Midwives for Maximizing Optimal Maternity Services (MOMS) Act of 2025 S. 1748/H.R. 6484, Kids Online Safety Act S. 1874/H.R. 3593, Title VIII Nursing Workforce Reauthorization Act of 2025 S. 2169, Rural Hospital Cybersecurity Enhancement Act S. 2857/H.R. 5448, Protecting Free Vaccines Act S. 2954, Health Care Workforce Expansion Act of 2025 S. 3199, 988 Lifeline Location Improvement Act of 2025 S. 3315, Health Care Cybersecurity and Resiliency Act of 2025 S. 3386, Health Care Freedom for Patients Act of 2025 S. 3853, End the Vaccine Carveout Act S. 4088, Welcome Back to the Health Care Workforce Act S. 4189, Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act Immigration: Legislation and policies related to: Detentions and deportation of children and families with children Authorization of the Deferred Action for Childhood Arrivals program Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 1061/S. 455, Protecting Sensitive Locations Act H.R. 6987/S. 3602 - Public Charge Clarification Act of 2025 H.R. 7640, Shut Down Sanctuary Policies Act S. 3805, End Sanctuary Cities Act of 2026 Labor Issues/Antitrust/Workplace: Legislation and policies related to: Workplace safety and violence prevention for nurse, advanced practice registered nurses, and other health care professionals Implementation of 42 USC 300gg-5(a) regarding provider non-discrimination by health plans H.R. 2531/S. 1232, Workplace Violence Prevention for Health Care and Social Services Workers Act H.R. 3170/S. 3296, Improving Access to Workers Compensation for Injured Federal Workers Act H.R. 4122/S. 2167, Health Care for Energy Workers Act of 2025 Medicare/Medicaid: Legislation and policies related to: Physician/nurse practitioner reimbursement Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Creation of a Medicare graduate nursing education program Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity Medicare and Medicaid policies related to telehealth services Medicaid eligibility expansion and state options Medicaid waiver application procedures Protection and improvement of Medicaid Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) benefit Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21), including the Rural Health Transformation Program Inclusion of nurse practitioners in the bonus program for clinicians practicing in primary care Health Professional Shortage Areas (HPSAs) H.R. 498, Do No Harm in Medicaid Act H.R. 1317/S. 575, Improving Care and Access to Nurses (I CAN) Act H.R. 1616/S. 1805, Promoting Access to Diabetic Shoes Act H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 2531/S. 1232, Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 2586, Reentry Act of 2025 H.R. 3108/S. 1535, Rural Patient Monitoring Access Act H.R. 3684, Save Americas Rural Hospitals Act H.R. 4231/S. 1973, Treat and Reduce Obesity Act H.R. 4619, Medicare Mental Health Inpatient Equity Act of 2025 H.R. 4773/S. 3350, ACO Assignment Improvement Act of 2025 H.R. 4849/S. 2556, Protecting Health Care and Lowering Costs Act H.R. 5081/S. 2709, Telehealth Modernization Act H.R. 5199, Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217, Rural Behavioral Health Improvement Act of 2025 H.R. 6199/S. 3934, Medical Nutrition Therapy Act of 2025 H.R. 7106, Enhancing Skilled Nursing Facilities Act H.R. 7787, Mental Health Workforce Act H.R. 7973, Momnibus Act S. 683/H.R. 7324, More Behavioral Health Providers Act S. 717/H.R. 6894, Increasing Access to Quality Cardiac Rehabilitation Care Act S. 1261/H.R. 4206, CONNECT for Health Act of 2025 S. 1816/H.R. 3514, Improving Seniors Timely Access to Care Act S. 1941, Cure Hepatitis C Act of 2025 S. 2954, Health Care Workforce Expansion Act of 2025 Taxation/Internal Revenue Code: Legislation and policies related to: Taxation of income and benefits and tax incentives affecting nursing education and practice Taxation of non-profit organizations Implementation of provisions of the One Big, Beautiful Bill Act (PL 119-21) H.R. 593, Strengthening Pathways to Health Professions Act H.R. 1582/S. 786, Personal Health Investment Today (PHIT) Act H.R. 3145/S. 1548, Nurse Corps Tax Parity Act of 2025 S. 46/H.R. 247, Health Care Affordability Act of 2025 S. 131/H.R. 392, Providing Real-World Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act Veterans: Legislation and policies related to: Revision and implementation of Department of Veterans Affairs regulation RIN 2900-AP44, Advanced Practice Registered Nurses H.R. 2234, Ensuring Veterans Timely Access to Anesthesia Care Act S. 3329/H.R. 6203, U.S. Cadet Nurse Corps Service Recognition Act

Government entities reported: Health & Human Services, Dept of (HHS) Health Resources & Services Administration (HRSA) HOUSE OF REPRESENTATIVES Natl Institutes of Health (NIH) Office of Management & Budget (OMB) SENATE Education, Dept of Environmental Protection Agency (EPA) Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Homeland Security, Dept of (DHS) Labor, Dept of (DOL) Occupational Safety & Health Administration (OSHA) Veterans Affairs, Dept of (VA)

Reported filing-period amount: $24,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

TOBACCO-FREE KIDS ACTION FUND

Registrant: TOBACCO-FREE KIDS ACTION FUND

1st Quarter (Jan 1 - Mar 31)
Apr 21, 2026

Reported lobbying issue

Tobacco: Lobbying Report: January 1st - March 31st, 2026 (Action Fund) Federal (under tobacco issue code) Legislation: H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs Appropriations Act FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping FDA authority over tobacco products Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes CDC Chronic disease prevention programs FDA enforcement against unauthorized tobacco products FDA review of flavored e-cigarettes FDA oversight of nicotine pouches Tobacco Harm Reduction Caucus Agencies Visited: Food and Drug Administration US House of Representatives US Senate Health Issues: GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 26 Appropriations bills Modernizing Opioid Treatment Access Act PEER Support Act H.R. 5420 - Workplace Overdose Reversal Kits to Save Lives Act S.3522 - No Red Tape For Addiction Treatment Act S. 1165/H. R. 2586, Reentry Act S. 1720/H.R. 1510, Due Process Continuity of Care Act S. 2697, Due Process Continuity of Care Act SUPPORT for Patients and Communities Reauthorization Act Issues: Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Financing (grants) for behavioral health care services and programs Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate

Government entities reported: Food & Drug Administration (FDA) HOUSE OF REPRESENTATIVES SENATE Centers For Disease Control & Prevention (CDC)

Reported filing-period amount: $430,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

CAMPAIGN FOR TOBACCO-FREE KIDS

Registrant: CAMPAIGN FOR TOBACCO-FREE KIDS

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Tobacco: Lobbying Report: January 1st - March 31st, 2026 (Campaign) Federal (under tobacco issue code) Legislation: H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs Appropriations Act FY 27 Commerce, Justice, Science, and Related Agencies Appropriations Act FY 27 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act FY 27 National Security, Department of State, and Related Programs Appropriations Act / State, Foreign Operations, and Related Programs Appropriations Act FY 27 Agriculture, Rural Development, and Related Agencies Appropriations Act S. 4257 Resources to Prevent Youth Vaping Act H.R. 7567 Farm, Food, and National Security Act of 2026 H.R. 2111, to amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. Issues: CDC tobacco prevention and cessation programs and funding Congressional Caucus to End Youth Vaping FDA authority over tobacco products Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes CDC Chronic disease prevention programs FDA enforcement against unauthorized tobacco products

Government entities reported: Food & Drug Administration (FDA) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

CAMPAIGN FOR TOBACCO-FREE KIDS

Registrant: CAMPAIGN FOR TOBACCO-FREE KIDS

4th Quarter (Oct 1 - Dec 31)
Feb 18, 2026

Reported lobbying issue

Tobacco: Lobbying Report: October 1st -December 31st, 2025 (Campaign) Federal (under tobacco issue code) Legislation: Comprehensive Tobacco Control Legislation H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs Appropriations Act H.R. 4121/S. 2256, FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Act H.R. 5371, FY 26 Continuing Appropriations, Agriculture, Leg. Branch, MCVA and Extensions Act H.R. 2111 Premium Cigar Bill Issues: CDC Office on Smoking and Health funding Congressional Caucus to Prevent Youth Vaping FDA authority over tobacco products Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes CDC Chronic disease prevention programs FDA authorization of tobacco products FDA tobacco product destruction authority FDA enforcement against unauthorized tobacco products Tobacco Harm Reduction Caucus

Government entities reported: Food & Drug Administration (FDA) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $10,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

CAMPAIGN FOR TOBACCO-FREE KIDS

Registrant: CAMPAIGN FOR TOBACCO-FREE KIDS

4th Quarter (Oct 1 - Dec 31)
Feb 18, 2026

Reported lobbying issue

Tobacco: Lobbying Report: October 1st -December 31st, 2025 (Campaign) Federal (under tobacco issue code) Legislation: Comprehensive Tobacco Control Legislation H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs Appropriations Act H.R. 4121/S. 2256, FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Act H.R. 5371, FY 26 Continuing Appropriations, Agriculture, Leg. Branch, MCVA and Extensions Act H.R. 2111 Premium Cigar Bill Issues: CDC Office on Smoking and Health funding Congressional Caucus to Prevent Youth Vaping FDA authority over tobacco products Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes CDC Chronic disease prevention programs FDA authorization of tobacco products FDA tobacco product destruction authority FDA enforcement against unauthorized tobacco products Tobacco Harm Reduction Caucus

Government entities reported: Food & Drug Administration (FDA) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $10,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

TOBACCO-FREE KIDS ACTION FUND

Registrant: TOBACCO-FREE KIDS ACTION FUND

4th Quarter (Oct 1 - Dec 31)
Feb 11, 2026

Reported lobbying issue

Tobacco: Lobbying Report: October 1st -December 31st, 2025 (Action Fund) Federal (under tobacco issue code) Legislation: Comprehensive Tobacco Control Legislation H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs Appropriations Act H.R. 4121/S. 2256, FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Act H.R. 5371, FY 26 Continuing Appropriations, Agriculture, Leg. Branch, MCVA and Extensions Act H.R. 2111 Premium Cigar Bill Issues: CDC Office on Smoking and Health funding Congressional Caucus to Prevent Youth Vaping FDA authority over tobacco products Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes CDC Chronic disease prevention programs FDA authorization of tobacco products FDA tobacco product destruction authority FDA enforcement against unauthorized tobacco products Tobacco Harm Reduction Caucus Agencies Visited: Food and Drug Administration US House of Representatives US Senate Health Issues: GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 26 Appropriations bills Modernizing Opioid Treatment Access Act PEER Support Act H.R. 5420 - Workplace Overdose Reversal Kits to Save Lives Act S.3522 - No Red Tape For Addiction Treatment Act S. 1165/H. R. 2586, Reentry Act S. 1720/H.R. 1510, Due Process Continuity of Care Act S. 2697, Due Process Continuity of Care Act SUPPORT for Patients and Communities Reauthorization Act Issues: Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate

Government entities reported: Food & Drug Administration (FDA) HOUSE OF REPRESENTATIVES SENATE Centers For Disease Control & Prevention (CDC)

Reported filing-period amount: $980,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

CAMPAIGN FOR TOBACCO-FREE KIDS

Registrant: CAMPAIGN FOR TOBACCO-FREE KIDS

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Tobacco: Lobbying Report: October 1st -December 31st, 2025 (Campaign) Federal (under tobacco issue code) Legislation: Comprehensive Tobacco Control Legislation H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs Appropriations Act H.R. 4121/S. 2256, FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Act H.R. 5371, FY 26 Continuing Appropriations, Agriculture, Leg. Branch, MCVA and Extensions Act H.R. 2111 Premium Cigar Bill Issues: CDC Office on Smoking and Health funding Congressional Caucus to Prevent Youth Vaping FDA authority over tobacco products Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes CDC Chronic disease prevention programs FDA authorization of tobacco products FDA tobacco product destruction authority FDA enforcement against unauthorized tobacco products Tobacco Harm Reduction Caucus

Government entities reported: Food & Drug Administration (FDA) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $10,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Health Issues: Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Mobile Cancer Screening Act, H.R. 4417, S. 2927. The bill would award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential screening services in rural and underserved communities. Breast Cancer Research Stamp Reauthorization Act of 2026, H.R.8358, S.4318. This bill would allow the U.S. Postal Service to extend its authority to issue the Breast Cancer Research semipostal stamp for 10 more years to raise funding for breast cancer research. Recognizing April as Cancer Prevention and Early Detection Month, H.Res.1196. The resolution would uplift the national commitment to cancer prevention and early detection to reduce the cancer burden and improve health outcomes for all Americans. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill would require group health plans and health insurers offering group or individual health insurance coverage to cover specified breast or chest wall reconstruction services related to breast cancer treatment. Medical Records Access Fairness Act, H.R.7790. The bill would require health care providers to give patients free access to their medical records at least once a year. Knock Out Cancer Act (H.R. 3873, or KO Cancer Act). The will would boost National Cancer Institute funding by 25% annually for FY2026-2030 to match cancers mortality toll and direct a report on drug shortages. Health Disparities Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Health Equity and Accountability Act. This bill advances policies to reduce health disparities and improve cancer prevention, research, and care for underserved communities. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Lainie Jones Comprehensive Cancer Survivorship Act, H.R. 8839. The bill would create pathways to address the financial challenges of cancer survivorship and maintain patients access to the health services needed to address the long-term effects of cancer. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Taxation/Internal Revenue Code: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Charity Parity Act, H.R. 8783, S. 4511. The bill would allow taxpayers to make direct qualified charitable distributions (QCDs) from their employer sponsored retirement plans. Tobacco: Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP). Budget/Appropriations: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. OMBs proposed Regulation for Federal Financial Assistance (May 2026). The changes in federal regulations would risk politicizing federal grant awards by empowering appointees to override scientific merit reviews, delaying cancer research progress, reducing transparency, and threatening NIH/CDC-funded breakthroughs that save lives. Medicare/Medicaid: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Medical/Disease Research/Clinical Labs: Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Asal Sayas National Strategy on Young Adult Cancers Act, S. 4717: Directs the NIH to develop a comprehensive national strategy to address the alarming rise of cancers in adults ages 18 to 49. American Cures Act, S. 4494. This bill would permanently fund several federal agencies and programs that perform biomedical research. Defense: Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP. Indian/Native American Affairs: Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.

Government entities reported: Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Natl Institutes of Health (NIH) SENATE Food & Drug Administration (FDA)

Reported filing-period amount: $1,240,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

TOBACCO-FREE KIDS ACTION FUND

Registrant: NVG, LLC

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Budget/Appropriations: Tobacco-related issues in the FY 2027 Agriculture, Rural Development, Food and Drug Administration, and related Agencies Appropriations bill. Funding for CDC Office on Smoking and Health in the FY2027 Labor-HHS Appropriations bill. Health Issues: Issues related to flavors in tobacco products. Issues related to regulation of e-cigarettes, including premarket applications and enforcement against illegal e-cigarettes. FDA pilot program for the expedited review of nicotine pouches. H.R.2111 - To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations. H.R.6845/S.3569 - S.T.O.P. Illicit Vapes Act.

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $50,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.

1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026

Reported lobbying issue

Health Issues: Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Health Disparities Nancy Gardner Sewell Medicare Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Taxation/Internal Revenue Code: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Tobacco: Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP). Budget/Appropriations: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. Medicare/Medicaid: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Medical/Disease Research/Clinical Labs: Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Defense: Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP. Indian/Native American Affairs: Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.

Government entities reported: Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Natl Institutes of Health (NIH) SENATE Food & Drug Administration (FDA)

Reported filing-period amount: $2,300,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN ACADEMY OF PEDIATRICS

Registrant: AMERICAN ACADEMY OF PEDIATRICS

4th Quarter (Oct 1 - Dec 31)
Feb 27, 2026

Reported lobbying issue

Health Issues: FY26 Labor, Health and Human Services, and Education Appropriations Bill: - Pediatric Subspecialty Loan Repayment Program - Firearm Injury and Mortality Prevention Research - Pediatric Mental Health Care Access Program - Emergency Medical Services for Children - National Center for Birth Defects and Developmental Disabilities - Global Immunization - Vaccine Injury Compensation Program - Antimicrobial Resistance - Maternal and Child Health Newborn Screening Saves Lives Reauthorization Act Strengthening the Vaccines for Children Program Act FY26 National Defense Authorization Act IDEA Full Funding Act (H.R.2598) PREEMIE Reauthorization Act (H.R.1197) Preventing Maternal Deaths Reauthorization Act of 2025 (H.R.1909) Artificial Intelligence TRICARE Autism Maternal mental health/perinatal mental health Vaccines Lifespan Respite Care Reauthorization Act (S.830/H.R.2560) FASD Respect Act (S.139) Family Vaccine Protection Act (H.R.3701) VACCINE Act HEADS UP Act (H.R.3409) Protecting Free Vaccines Act PREVENT HPV Cancers Act (H.R.6561) Vaccine Transportation Access Act MDUFA VI Reauthorization Innovation in Pediatric Drugs Act (S.705) & Policies to Strengthen Pediatric Research Equity Act Best Pharmaceuticals for Children Act Pediatric Research Equity Act Prescription Drug User Fee Amendments Pediatric IBD Drug Development Health Information Privacy Reform Act (S.3097) Child passenger safety Appropriations for the Indian Health Service Appropriations for Environmental Programs (including EPA) Maternal, Infant, and Early Childhood Home Visiting Program & Implementation Infant sleep product safety Lead exposure prevention Food safety Paid family and medical leave Regulation of high-powered magnet sets Vehicle emissions standards Button battery ingestions Early childhood education (including Head Start, Childcare) Child product safety and injury prevention, including drowning prevention Child Abuse Prevention and Treatment Act (CAPTA) Family First Prevention Services Act implementation Title IV-B Congregate care reform Mental health supports for foster youth/former foster youth Mercury and Air Toxics Standards, ozone and particulate matter NAAQS, EPA greenhouse gas regulation, Endangerment Finding QRTP/IMDs Firearm Injury and Violence Prevention (Including Research Funding; Background Checks; Safe/Secure Storage) Childcare Funding & Resources Native American Child Health Water Beads Vaccines Fluoride Child Welfare & Medicaid, Social Services Block Grant (SSBG), Temporary Assistance for Needy Families (TANF), and Supplemental Nutrition Assistance Program (SNAP) Housing Prematurity Research Expansion and Education for Mothers who Deliver Infants Early (PREEMIE) Reauthorization Act of 2025 (S.1562/H.R.1197) Newborn Screening Saves Lives Reauthorization Act (H.R.4709) Donor Milk Title V Maternal and Child Health (MCH) Services Block Grant SSI Savings Penalty Elimination Act (S.1234/H.R.2590) Supplemental Security Income Equality Act (H.R.2540) Autonomous Vehicles Pregnancy Risk Assessment Monitoring System (PRAMS) Data Collection Project Toxic Substances Control Act (TSCA) & Potential Changes Medicaid Payment Parity (including H.R.1433 / S.760 - Kids Access to Primary Care Act) Access to Care in Medicaid/CHIP Medicaid/CHIP federal funding Accelerating Kids Access to Care Act (H.R.1509 / S.752) H.R.4641 - Keep Kids Covered Act S.2287/H.R.4425 - Palliative Care and Hospice Education and Training Act (PCHETA) Telehealth - Medicare telehealth extension, CONNECT for Health Act (S.1261) One Big Beautiful Bill Act (H.R.1) Proposed Rulemaking: Medicaid Program; Prohibition on Federal Medicaid and Children's Health Insurance Program Funding for Sex-Rejecting Procedures Furnished to Children (CMS-2451-P) and Medicare and Medicaid Programs; Hospital Condition of Participation: Prohibiting Sex-Rejecting Procedures for Children (CMS-3481-P) Children and Teens Online Privacy Protection Act (H.R.6291/S.836) Kids Online Safety Act (H.R.6484/S.1748) Artificial Intelligence and Child Health Legislation to Protect Young People Online Pediatric Specialty Loan Repayment Program Funding and Program Implementation EMPOWER for Health Act Regulation/Enforcement of Tobacco Products - Tobacco TRACE Act (H.R.6845) - STOP Illicit Vaping Act (H.R.6844/S.3569) Funding for Tobacco Control Programs Biomedical Research Funding (NIH, NICHD, AHRQ) LGBTQ Health Care Financing and Access - H.R.3492 - H.R.498 LGBTQ Health Care Financing and Access - Medicare and Medicaid Programs; Hospital Condition of Participation: Prohibiting Sex-Rejecting Procedures for Children (CMS-3481-P) - Medicaid Program; Prohibition on Federal Medicaid and Children's Health Insurance Program Funding for Sex-Rejecting Procedures Furnished to Children (CMS-2451-P) Global Child Thrive Reauthorization Act Notice of Proposed Rulemaking DHS Docket No. USCIS-2025-0304 The Department of State Reauthorization Act Protecting Sensitive Locations Act (H.R.5166 / S.455) Federal HIV Guidelines Family Detention / DHS policies Unaccompanied Children's Program / Office of Refugee Resettlement Child Nutrition Reauthorization/WIC SNAP/Farm Bill Mental Health for Children Medical Foods and Formulas Access Act WIC Act MODERN WIC Act Breastfeeding Peer Counseling Program Mental Health Services for Students Act of 2025 (H.R.5557) School Meals Expansion Funding for HRSA Pediatric Mental Health Care Access Program Funding for WIC Donor Milk Dietary Guidelines

Government entities reported: Administration for Children & Families (ACF) Agriculture, Dept of (USDA) Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Consumer Product Safety Commission (CPSC) Drug Enforcement Administration (DEA) Environmental Protection Agency (EPA) Food & Drug Administration (FDA) Health & Human Services, Dept of (HHS) Health Resources & Services Administration (HRSA) HOUSE OF REPRESENTATIVES Housing & Urban Development, Dept of (HUD) Indian Health Service Interior, Dept of (DOI) Natl Institutes of Health (NIH) Office of the Comptroller of the Currency (OCC) SENATE Social Security Administration (SSA) State, Dept of (DOS) U.S. Agency for International Development (USAID)

Reported filing-period amount: $100,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.

4th Quarter (Oct 1 - Dec 31)
Jan 20, 2026

Reported lobbying issue

Health Issues: Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Education and Awareness Requires Learning (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Health Disparities Nancy Gardner Sewell Medicare Early Detection Screening Coverage Act, H.R. 842, S. 339. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Equality Act, H.R. 15, S. 1503. This bill prohibits discrimination based on sex, sexual orientation, or gender identity with respect to businesses, employment, housing, federally funded programs, and other settings. Henrietta Lacks Congressional Gold Medal Act, H.R. 3498, S.1893. Legislation to award posthumously a Congressional Gold Medal to Henrietta Lacks, in recognition of her immortal cells which have made invaluable contributions to global health, scientific research, our quality of life, and patients' rights. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, S.752, H.R.1509. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, S.932, S. 3302, H.R. 1262. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Taxation/Internal Revenue Code: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years. Tobacco: Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Budget/Appropriations: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY25 Labor, Health, and Human Services CR provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY26 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY26 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY26 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY26 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. Medicare/Medicaid: One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, H.R. 842, S.339. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, S.752, H.R. 150. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Medical/Disease Research/Clinical Labs: Clinical Trial Modernization Act, H.R. 3521. Increase diversity in access to clinical trials and make it easier for all persons with cancer to participate by reducing barriers to enrollment. Barriers may include ancillary (non-medical) costs, such as transportation and lodging, and remote access to trials, particularly for people who are underrepresented, including certain racial and ethnic groups, older adults, rural residents, and those with limited incomes. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Defense: Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP. Indian/Native American Affairs: Issues relating to Indian Health Services and the Congressional Native American Caucus. FY26 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY26 and advanced FY27 appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY26 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.

Government entities reported: Centers For Disease Control & Prevention (CDC) Centers For Medicare and Medicaid Services (CMS) Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES Natl Institutes of Health (NIH) SENATE Food & Drug Administration (FDA)

Reported filing-period amount: $2,380,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗
Discussion notificationsSign in to subscribe
?
No comments yet. Start the conversation.